Find out what’s new at the Lung Cancer Research Foundation. Included below are researcher spotlights, recent developments in lung cancer research — from LCRF grant recipients as well as others in the field, highlights from our signature fundraising events and more.
For media inquiries, please contact Senior Director of Marketing & Communications Emily Krimbel at ekrimbel@lcrf.org.
The 12th Annual Tom Zangas Memorial Lung Cancer Foundation/Archangel Michael 5K Run/1K Walk raised more than $60,000 this year. Funds benefit research through the Lung Cancer Research Foundation and NYU Langone Perlmutter Cancer Center.
The Lung Cancer Research Foundation (LCRF) announced the awardees of its 2019 Scientific Grant Program during the Fourteenth Annual Lung Cancer Awareness Luncheon held November 12 in New York City.
This November and December, LCRF is shining a spotlight on lung cancer and Its effects on women.
A team of 10 runners represented the Lung Cancer Research Foundation at the TCS New York City Marathon on Sunday, November 3. Together they have raised over $70,000 for lung cancer research!
LCRF was well represented at the IASLC 20th World Conference on Lung Cancer in Barcelona. The discussions at this year’s conference highlighted the importance of lung cancer screening, biomarker testing, and advocating for more lung cancer research funding.
Kortni and Tiffany from the Chicago Lung Run's Team DeMuffy share why funding lung cancer research is so important to them. Focusing on that purpose has mobilized their team.
The FDA approved a targeted therapy entrectinib (Rozlytrek) for either NTRK+ solid tumors* or ROS1+ patients with metastatic non-small cell lung cancer (NSCLC).
The Southampton Community joined together August 11, 2019 for the Lung Cancer Research Foundation's Fourteenth Annual Strides for Life run/walk. Nearly 600 walkers and runners raised more than $365,000 to fund lung cancer research.
LCRF grantee Dr. Trudy Oliver and her lab at the University of Utah are making news in the world of small cell lung cancer (SCLC).
Dr. Trudy Oliver, a 2018 LCRF research grant recipient, explains how research affects what lung cancer patients experience when they go for treatment.
The FDA approved a new treatment for small cell lung cancer on June 17.
The Lung Cancer Research Foundation has awarded $300,000 in research grants for projects addressing lung cancer disparities. Funding was provided with support from the Stavros Niarchos Foundation.
The Lung Cancer Research Foundation was featured on the May 26 episode of WISC-TV's For the Record, hosted by Josh Spreiter. WISC-TV News3 Channel3000 is the media partner for Madison Free to Breathe Yoga, which was the focus of the segment.
The Lung Cancer Research Foundation (LCRF) has announced that Dr. Katerina Politi has been named the chair of its Scientific Advisory Board.
The Lung Cancer Research Foundation is delighted to continue our partnership with Merck on Your Cancer Game Plan and the launch of a new program, With Love, Me.
At 38, with three small children, Jen faced a lung cancer diagnosis. Research discoveries mean that she's still here with them.
Over $1 Million in Research Grants to be Awarded for Research into Management of Targeted Therapy Side Effects
The FDA has approved pembrolizumab for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC).
The Lung Cancer Research Foundation is now accepting applications for the 2018 Pilot Grant Program. Applications will be accepted through June 14, 2019.
The Lung Cancer Research Foundation’s strong financial health and commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator